| Aspirin Versus Anticoagulants in Symptomatic Intracranial Stenosis. |
AVASIS |
N/A |
 |
| Antiphospholipid Antibodies and Stroke Study |
APASS |
N/A |
|
| Patent Foramen Ovale in Cryptogenic Stroke Study |
PICSS |
4 |
|
| Stroke Prevention in Atrial Fibrillation III |
SPAF III |
N/A |
|
| Stroke Prevention in Reversible Ischemia Trial |
SPIRIT |
3 |
|
| Warfarin Versus Aspirin Recurrent Stroke Study |
|
3 |
|
| Warfarin-Aspirin Symptomatic Intracranial Disease Study |
WASID |
3 |
|
| Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study |
AFASAK II |
3 |
|
| Stroke Prevention in Atrial Fibrillation II |
SPAF II |
N/A |
|
| Primary Prevention of Arterial Thromboembolism in Nonrheumatic Atrial Fibrillation |
PATAF |
3 |
|
| Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial |
WARCEF |
3 |
 |
| Warfarin-Aspirin Symptomatic Intracranial Disease Study - Retrospective |
WASID-R |
N/A |
|
| Asymptomatic Carotid Artery Plaque Study |
ACAPS |
N/A |
|
| European Atrial Fibrillation Trial |
EAFT |
N/A |
|
| Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF) |
|
3 |
|
| Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators |
SPINAF |
N/A |
|
| Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study |
JNAF-ESP |
N/A |
|
| Long-term anticoagulation in stroke patients with atrial fibrillation |
|
N/A |
|
| Canadian Atrial Fibrillation Anticoagulation Study |
CAFA |
N/A |
|
| Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) |
|
3 |
|
| Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks |
|
N/A |
|
| Stroke Prevention by ORal Thrombin Inhibition V |
SPORTIF V |
N/A |
|
| Aortic Arch Related Cerebral Hazard Trial (ARCH) |
ARCH |
3 |
|
| RESPECT PFO Clinical Trial |
|
2 |
|
| Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study |
AFASAK I |
N/A |
|
| Birmingham Atrial Fibrillation Treatment of the Aged |
BAFTA |
N/A |
|
| National Study for Prevention of Embolism in Atrial Fibrillation |
NASPEAF |
N/A |
|
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) |
|
3 |
 |
| Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients |
|
2 |
|
| Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate |
|
3 |
|
| Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information |
|
N/A |
|
| Comparative study of the stability of oral anticoagulant therapy using phenprocoumon or warfarin. |
|
N/A |
|
| Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation |
EngageAFTIMI48 |
3 |
|
| Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation |
|
2 |
|
| Warfarin and Antiplatelet Vascular Evaluation |
|
3 |
|
| An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation |
|
3 |
|
| Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation |
ARISTOTLE |
3 |
|
| Cervical Artery Dissection In Stroke Study: Feasibility Phase. |
CADISS |
N/A |
 |
| Clinical and Economic Implications of Genetic Testing for Warfarin Management |
|
4 |
|
| Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack |
PERFORM |
N/A |
|
| Patent Foramen Ovale in Cryptogenic Stroke Study |
PICSS |
4 |
|
| Aspirin Or Warfarin To Prevent Stroke |
|
3 |
|
| Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation |
BOREALIS-AF |
3 |
|
| Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation |
|
3 |
|
| Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation |
|
2 |
|
| Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection |
|
1 |
|
| Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy |
PREVAIL |
3 |
|
| PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin |
|
2 |
|
| Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients |
FORESPEAK-0 |
2 |
|
| A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation |
OPAL-2 |
2 |
|
| Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin |
EXPLORE-Xa |
2 |
|
| The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation |
|
4 |
|
| Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke |
AHSCTIS |
1 |
|
| Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease |
|
4 |
 |
